Moffitt logo

Articles related to Immunotherapy

Immuno Oncology Highlights

Highlights of Moffitt Science Presented at Tandem Meetings of ASTCT and CIMBTR

Moffitt scientists are presenting advances in areas like cellular immunotherapy for relapsed or refractory (R/R) acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), acute lymphoblastic leukemia (ALL), lymphoma, multiple myeloma (MM) and allogeneic HCT. Read More

TIL Therapy Lab 890

Clinscience and OncoBay Clinical Partner to Expand Immuno-Oncology Research Globally

The Polish clinical research organization Clinscience made a major investment in OncoBay to partner on projects in the U.S. and Europe Read More

Johnny Building Ministry 640X367

Spreading Hope and Building on Faith Through A Cancer Journey

Celebrating a Life of Ministry and a Multiple Myeloma Milestone with a Very Special Patient Read More

Gary Lambert Coffee Sourcing (3)

A Unique Take on Customized Cancer Care

Husband, father and coffee aficionado Gary has become one of the first 100 patients to be treated with CAR T therapy approved for myeloma Read More

Cell Therapies 640

Cellular Immunotherapy Highlights from ASCO

Moffitt’s physicians and scientists were proud to share and present their cellular immunotherapy research findings at American Society of Clinical Oncology (ASCO 2022) Read More

Cell Therapy Clinical Perspectives

New Non-Small Cell Lung Cancer Biomarkers Found

New non-small cell lung cancer biomarker: Distinct ecologies exist between disease that does and does not progress. Read More

Cell Therapy Clinical Perspectives

Promises of Cell Therapy Bring Opportunities for Collaboration and Clinical Excellence

Finding ways to act on discrete targets on or within cancerous cells without affecting healthy cells is a key focus of several Moffitt research efforts. Read More


TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer

A group of investigators at Moffitt Cancer Center initiated a trial to determine if non-small cell lung cancer patients could have response to TIL therapy Read More


Immunotherapy Clinical Trial Brought Renewed Hope To Lung Cancer Patient

My husband and I celebrated our 50th wedding anniversary last year and know without a doubt that I would not be alive today if we had not sought treatment at Moffitt Cancer Center. Read More


Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy

Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More


Infographic: How CAR T Therapy Works to Fight Cancer

CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More


What is CAR T Therapy?

Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More


CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma

Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More


Research Spotlight: Dr. Abate-Daga Discusses the Progress of Immunotherapy

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More


Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More